Is Single Dose XXXX Sclerotherapy Effective in Chyluria?

@entity1 @entity1674 @entity812 @entity4279
UNASSIGNED: Background: Chyluria is a chronic debilitating condition characterized by formation of pyelo-lymphatic connections. Renal pelvic instillation sclerotherapy is a minimally invasive treatment modality in treatment of chyluria. Various sclerosant with different regimen have been described in literature but there is no single consensus on this regard. Objective: To evaluate the effectiveness and safety of single dose 0.2% @entity4279 renal pelvic instillation sclerotherapy for the treatment of chyluria. Methods: In a prospective study from August 2010 till July 2013, forty one @entity1 presenting with milky urine were included. Apart from ether test, presence of lymphocytes in urine and urine @entity1674 levels were also done to confirm chyluria. On a day care basis under local anesthesia 5F open ended ureteric catheter was introduced in the ureteric orifice of affected side. Freshly prepared 7-10ml of 0.2% @entity4279 solution was instilled with the @entity1 in Trendelenburg position. Results: Total of 41 @entity1 were enrolled ( 27 males and 14 females; mean age 40 years, SD 8.9, range 19-61) with a mean follow up of 20 months. Immediate clearance was seen in all @entity1 and recurrence in 7 (17%). Mean disease free duration was 18 months. Two @entity1 had moderate to severe @entity812 . Conclusion: Single dose 0.2% @entity4279 sclerotherapy is safe and effective treatment for chyluria. As it offers treatment on a day care basis, continuous ureteral and urethral catheterizations can be avoided.
